Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat neuronal protein 1 (LRRN1) is a single-pass transmembrane glycoprotein characterized by extracellular LRR motifs, immunoglobulin-like and fibronectin type III domains, and a short intracellular tail. It is expressed predominantly in neural progenitor cells and is involved in regulation of synapse assembly, neural development, and stem cell pluripotency. LRRN1 plays roles in cell-cell adhesion, signal transduction, and maintenance of key transcription factor stability in stem cells. Aberrant LRRN1 expression is linked to progression and poor prognosis in several cancers, especially gastric cancer and neuroblastoma, acting through suppression of apoptosis and interaction with oncogenic growth pathways such as ALK signaling. The gene is also implicated in neurodevelopmental disorders, including autism spectrum disorder and intellectual disability. LRRN1 is considered a biomarker for gastric cancer and is a candidate therapeutic target due to its disease-related functions and interactions.
Negative regulation of ALK receptor tyrosine kinase signaling (extracellular domain interaction); Inhibition of apoptosis (through suppression of Fas/FasL pathway and JUN activation); Stabilization of key transcription factors in stem cells by preventing nuclear export (via AKT-mediated mechanisms).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat neuronal protein 1 (LRRN1).